Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma

BACKGROUND: The aim of the study reported here was to evaluate the feasibility and safety of raltitrexed and nedaplatin with concurrent radiotherapy in patients with unresectable, locally advanced esophageal squamous cell carcinoma (ESCC). METHODS: Eligible patients were adults with newly diagnosed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Qiu, Xiangnan, Li, Jing, Zhou, Han, Zhang, Meng, Jiang, Changchen, Shen, Zetian, Zhu, XiXu, Li, Aomei, Che, Yuxin, Wu, Tiancong, Wang, Zhen
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2020
Assuntos:
5700
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004679/
https://ncbi.nlm.nih.gov/pubmed/31977864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000018732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados